Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00106899 · ClinicalTrials.gov registry record
ADNI: Alzheimer's Disease Neuroimaging Initiative
A clinical trial, sponsored by Alzheimer's Disease Cooperative Study (ADCS).
- Completed
- Registry status
- 818
- Enrollment target
NCT00106899: Completed study, sponsored by Alzheimer's Disease Cooperative Study (ADCS).
NCT00106899 is a clinical trial that has completed, run by Alzheimer's Disease Cooperative Study (ADCS). The registered enrollment target is 818 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00106899 has completed, sponsored by Alzheimer's Disease Cooperative Study (ADCS).
- COMPLETED
- Registry status
- 818 participants
- Enrollment target
Study Summary
The purpose of this study is to examine how brain imaging technology can be used with other tests to measure the progression of mild cognitive impairment (MCI) and early Alzheimer's disease (AD). This information will aid future clinical trials by providing a standard assessment tool to measure the effects of treatments being studied.
Interventions
- PROCEDURE Magnetic Resonance Imaging (MRI)
- PROCEDURE Positron Emission Tomography (PET)
- PROCEDURE Lumbar Puncture (LP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 818 participants |
| Start Date | 2005-07 |
| Est. Completion | 2011-06 |
What the finished NCT00106899 record still lists
NCT00106899 is an observational study that tracks outcomes without assigning an intervention. The registered 818 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Magnetic Resonance Imaging (MRI) is the first listed.
NCT00106899 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00106899 about?
NCT00106899 is a clinical study titled "ADNI: Alzheimer's Disease Neuroimaging Initiative". The purpose of this study is to examine how brain imaging technology can be used with other tests to measure the progression of mild cognitive impairment (MCI) and early Alzheimer's disease (AD). This information will aid future clinical trials by providing a standard assessment tool to measure the ...
What is the current status of trial NCT00106899?
This trial is currently completed. The enrollment target is 818 participants. The study started on 2005-07. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00106899?
The interventions under investigation include: Magnetic Resonance Imaging (MRI) (PROCEDURE), Positron Emission Tomography (PET) (PROCEDURE), Lumbar Puncture (LP) (PROCEDURE).
Who is sponsoring clinical trial NCT00106899?
This trial is sponsored by Alzheimer's Disease Cooperative Study (ADCS), which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04846959 · 818 participants
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
- NCT04028687 · 820 participants
MDR - PMCF Study for Taperloc Complete Stems
- NCT04613440 · 820 participants · NA
FaCT Trial (Facilitated Cascade Testing Trial)
- NCT04910269 · 820 participants · Phase 3
Outpatient Treatment With Anti-Coronavirus Immunoglobulin
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia